Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kathrin Hanke-Müller"'
Autor:
Tamina Rückert, Geoffroy Andrieux, Melanie Boerries, Kathrin Hanke-Müller, Nadine M. Woessner, Stephanie Doetsch, Christoph Schell, Konrad Aumann, Julia Kolter, Annette Schmitt-Graeff, Marcel Schiff, Lukas M. Braun, Eileen Haring, Sandra Kissel, Benjamin A. Siranosian, Ami S. Bhatt, Peter Nordkild, Jan Wehkamp, Benjamin A. H. Jensen, Susana Minguet, Justus Duyster, Robert Zeiser, Natalie Köhler
Publikováno v:
Science translational medicine. 14(676)
Acute graft-versus-host disease (aGVHD), which is driven by allogeneic T cells, has a high mortality rate and limited treatment options. Human β-defensin 2 (hBD-2) is an endogenous epithelial cell–derived host-defense peptide. In addition to its a
Autor:
Justyna Rawluk, Frank Meiss, Melanie Boerries, Annette Schmitt-Graeff, Federico Simonetta, Robert S. Negrin, Severin Dicks, Justus Duyster, David Rafei-Shamsabadi, Robert Zeiser, Martina Falk, Natalie Köhler, Konrad Aumann, Sandra Duquesne, Nora Rebeka Javorniczky, Patrick Marschner, Manching Ku, Kathrin Hanke-Müller, Dominik Marschner, Eileen Haring
Publikováno v:
JCI Insight, Vol. 5, No 6 (2020) P. 1317
JCI Insight
JCI Insight
Immune checkpoint inhibitor (ICI) therapy has shown a significant benefit in the treatment of a variety of cancer entities. However, immune-related adverse events (irAEs) occur frequently and can lead to ICI treatment termination. MicroRNA-146a (miR-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bddb817444cfc4cfd247a46fdf52174d
https://archive-ouverte.unige.ch/unige:156449
https://archive-ouverte.unige.ch/unige:156449